Antidiabetic drugs, glycemic control and risk of benign prostatic hyperplasia.

Lotta H Nygård,Kirsi Talala,Kimmo Taari,Teuvo L J Tammela,Anssi Auvinen,Teemu J Murtola

The Prostate（2023）

引用 0|浏览27

暂无评分

摘要

Diabetic BGL and antidiabetic medication use, especially insulin, are associated with an elevated risk of BPH surgery compared to nondiabetic men. These findings support the roles of insulin use and untreated hyperglycemia as possible BPH risk factors.

查看译文

关键词

antidiabetic drugs,benign prostatic hyperplasia,blood glucose,cohort,risk

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要